{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:41:18Z","timestamp":1792611678868,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P51OD011092"],"award-info":[{"award-number":["P51OD011092"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.contraception.2022.03.016","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T06:38:40Z","timestamp":1648708720000},"page":"43-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Mechanism of action of a 0.075 mg norgestrel progestogen-only pill 2. Effect on cervical mucus and theoretical risk of conception"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2018-6028","authenticated-orcid":false,"given":"Leo","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell D","family":"Creinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Hemon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Glasier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2022.03.016_bib0001","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0010-7824(74)90061-4","article-title":"A randomized contraceptive trial comparing a daily progestogen with a combined oral contraceptive steroid","volume":"9","author":"Paulsen","year":"1974","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.03.016_bib0002","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0010-7824(82)90047-6","article-title":"A randomized, double-blind study of two combined and two progestogen-only oral contraceptives","volume":"25","author":"Sheth","year":"1982","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.03.016_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/0010-7824(94)90113-9","article-title":"Progestin-only oral contraception: a comprehensive review: II. Mode of action","volume":"50","author":"McCann","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.03.016_bib0004","series-title":"Speroff & Darney's Clinical Guide to Contraception","author":"Jensen","year":"2019"},{"key":"10.1016\/j.contraception.2022.03.016_bib0005","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0002-9378(72)90617-5","article-title":"A composite picture of the menstrual cycle","volume":"114","author":"Moghissi","year":"1972","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2022.03.016_bib0006","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.contraception.2017.07.168","article-title":"Cervical mucus and contraception: what we know and what we don't","volume":"96","author":"Han","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.03.016_bib0007","doi-asserted-by":"crossref","first-page":"e29208","DOI":"10.2196\/29208","article-title":"Assessing the pregnancy protective impact of scheduled nonadherence to a novel progestin-only pill: protocol for a prospective, multicenter, randomized, crossover study","volume":"10","author":"Edelman","year":"2021","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.contraception.2022.03.016_bib0008","unstructured":"CooperSurgical. Unimar Aspirette Device Description n.d. www.coopersurgical.com\/...\/36024-DFU.pdf (accessed September 4, 2014)."},{"key":"10.1016\/j.contraception.2022.03.016_bib0009","first-page":"1","article-title":". Laboratory manual of the WHO for the examination of human semen and sperm-cervical mucus interaction","volume":"37","year":"2001","journal-title":"Ann DellIstituto Super Sanit\u00e0"},{"key":"10.1016\/j.contraception.2022.03.016_bib0010","first-page":"2785","article-title":"A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception","volume":"30","author":"Brache","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2022.03.016_bib0011","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0010-7824(93)90025-3","article-title":"Ultrasound evaluation of ovarian activity under oral contraceptives","volume":"47","author":"Hoogland","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.03.016_bib0012","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.contraception.2020.05.013","article-title":"The effects on ovarian activity of delaying versus immediately restarting combined oral contraception after missing three pills and taking ulipristal acetate 30 mg","volume":"102","author":"Banh","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.03.016_bib0013","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3109\/13625187.2015.1048331","article-title":"Monitoring the menstrual cycle: comparison of urinary and serum reproductive hormones referenced to true ovulation","volume":"20","author":"Roos","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2022.03.016_bib0014","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/13625187.2018.1437134","article-title":"Appraising cervical mucus: a new approach to evaluating contraceptives","volume":"23","author":"Han","year":"2018","journal-title":"The European Journal of Contraception & Reproductive Health Care"},{"key":"10.1016\/j.contraception.2022.03.016_bib0015","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0015-0282(16)38342-X","article-title":"Effects of microdose norgestrel on endogenous gonadotropic and steroid hormones, cervical mucus properties, vaginal cytology, and endometrium","volume":"22","author":"Moghissi","year":"1971","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2022.03.016_bib0016","first-page":"173","article-title":"Norgestrel induced cervical barrer to sperm migration","volume":"5","author":"Roland","year":"1968","journal-title":"J Reprod Fertil Suppl"},{"key":"10.1016\/j.contraception.2022.03.016_bib0017","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/13625187.2015.1044082","article-title":"A randomised study comparing the effect on ovarian activity of a progestogen-only pill (POP) containing desogestrel and a new POP containing drospirenone in a 24\/4 regimen","volume":"20","author":"Duijkers","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2022.03.016_bib0018","series-title":"Cochrane Database Syst. Rev.","article-title":"Progestin-only pills for contraception","author":"Grimes","year":"1996"},{"key":"10.1016\/j.contraception.2022.03.016_bib0019","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.contraception.2016.03.006","article-title":"Impact of obesity on the pharmacokinetics of levonorgestrel-based emergency contraception: single and double dosing","volume":"94","author":"Edelman","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.03.016_bib0020","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.contraception.2010.01.016","article-title":"Pharmacokinetics of a combined oral contraceptive in obese and normal weight women","volume":"81","author":"Westhoff","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.03.016_bib0021","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/13625187.2019.1605503","article-title":"Comparing cervical mucus changes in response to an oral progestin or estrogen withdrawal in ovarian suppressed women: a clinical pilot","volume":"24","author":"Han","year":"2019","journal-title":"Eur J Contracept Reprod Health Care Off J Eur Soc Contracept"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782422000774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782422000774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T21:12:11Z","timestamp":1762117931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782422000774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":21,"alternative-id":["S0010782422000774"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2022.03.016","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of action of a 0.075 mg norgestrel progestogen-only pill 2. Effect on cervical mucus and theoretical risk of conception","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2022.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}